Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppression

PD-L1-mediated immune escape plays an important role in cancer development and progression. Targeting PD-L1 is consider to be an attractive approach for cancer treatment. PD-L1 is a heavily N-linked glycosylated protein, and the glycosylation of PD-L1 is essential for its ability to interact with it...

Full description

Bibliographic Details
Main Authors: Zhenou Sun, Xuan Ma, Chong Zhao, Lihong Fan, Shutao Yin, Hongbo Hu
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223018760
_version_ 1797364203588157440
author Zhenou Sun
Xuan Ma
Chong Zhao
Lihong Fan
Shutao Yin
Hongbo Hu
author_facet Zhenou Sun
Xuan Ma
Chong Zhao
Lihong Fan
Shutao Yin
Hongbo Hu
author_sort Zhenou Sun
collection DOAJ
description PD-L1-mediated immune escape plays an important role in cancer development and progression. Targeting PD-L1 is consider to be an attractive approach for cancer treatment. PD-L1 is a heavily N-linked glycosylated protein, and the glycosylation of PD-L1 is essential for its ability to interact with its receptor PD-1 to mediate immune suppression. In the present study, we demonstrated for the first time that delta-tocotrienol (δ-T3) not any of the other forms of vitamin E was able to disrupt PD-L1 glycosylation mechanistically associated with the suppression of TCF4-STT3a/STT3b axis. The inhibition of PD-L1 glycosylation by δ-T3 resulted in the decrease of PD-L1 expression and its exosomal secretion, leading to the reduction of PD-L1 and PD-1 interaction, and reversing PD-L1-mediated immune suppression, which in turn contributed to the inhibitory effect on tumor growth. The findings of the present study provide a novel mechanistic interpretation for the superior anticancer activity of δ-T3 among 8 isomers of the vitamin E.
first_indexed 2024-03-08T16:32:54Z
format Article
id doaj.art-0d870d99cd9e4610aac7248074157399
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-03-08T16:32:54Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-0d870d99cd9e4610aac72480741573992024-01-06T04:38:12ZengElsevierBiomedicine & Pharmacotherapy0753-33222024-01-01170116078Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppressionZhenou Sun0Xuan Ma1Chong Zhao2Lihong Fan3Shutao Yin4Hongbo Hu5College of Food Science and Nutritional Engineering, Beijing Key Laboratory for Food Non-thermal Processing, China Agricultural University, No.17 Qinghua East Road, Haidian District, Beijing 100083, China; College of Food Science and Nutritional Engineering, Tianjin University of Science and Technology, Tianjin, ChinaCollege of Food Science and Nutritional Engineering, Beijing Key Laboratory for Food Non-thermal Processing, China Agricultural University, No.17 Qinghua East Road, Haidian District, Beijing 100083, China; College of Biochemical Engineering, Beijing Union University, Beijing, ChinaCollege of Food Science and Nutritional Engineering, Beijing Key Laboratory for Food Non-thermal Processing, China Agricultural University, No.17 Qinghua East Road, Haidian District, Beijing 100083, ChinaCollege of Veterinary Medicine, China Agricultural University, Beijing, ChinaCollege of Food Science and Nutritional Engineering, Beijing Key Laboratory for Food Non-thermal Processing, China Agricultural University, No.17 Qinghua East Road, Haidian District, Beijing 100083, China; Corresponding authors.College of Food Science and Nutritional Engineering, Beijing Key Laboratory for Food Non-thermal Processing, China Agricultural University, No.17 Qinghua East Road, Haidian District, Beijing 100083, China; Corresponding authors.PD-L1-mediated immune escape plays an important role in cancer development and progression. Targeting PD-L1 is consider to be an attractive approach for cancer treatment. PD-L1 is a heavily N-linked glycosylated protein, and the glycosylation of PD-L1 is essential for its ability to interact with its receptor PD-1 to mediate immune suppression. In the present study, we demonstrated for the first time that delta-tocotrienol (δ-T3) not any of the other forms of vitamin E was able to disrupt PD-L1 glycosylation mechanistically associated with the suppression of TCF4-STT3a/STT3b axis. The inhibition of PD-L1 glycosylation by δ-T3 resulted in the decrease of PD-L1 expression and its exosomal secretion, leading to the reduction of PD-L1 and PD-1 interaction, and reversing PD-L1-mediated immune suppression, which in turn contributed to the inhibitory effect on tumor growth. The findings of the present study provide a novel mechanistic interpretation for the superior anticancer activity of δ-T3 among 8 isomers of the vitamin E.http://www.sciencedirect.com/science/article/pii/S0753332223018760Vitamin Eδ-tocotrienolPD-L1GlycosylationImmune suppression
spellingShingle Zhenou Sun
Xuan Ma
Chong Zhao
Lihong Fan
Shutao Yin
Hongbo Hu
Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppression
Biomedicine & Pharmacotherapy
Vitamin E
δ-tocotrienol
PD-L1
Glycosylation
Immune suppression
title Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppression
title_full Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppression
title_fullStr Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppression
title_full_unstemmed Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppression
title_short Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppression
title_sort delta tocotrienol disrupts pd l1 glycosylation and reverses pd l1 mediated immune suppression
topic Vitamin E
δ-tocotrienol
PD-L1
Glycosylation
Immune suppression
url http://www.sciencedirect.com/science/article/pii/S0753332223018760
work_keys_str_mv AT zhenousun deltatocotrienoldisruptspdl1glycosylationandreversespdl1mediatedimmunesuppression
AT xuanma deltatocotrienoldisruptspdl1glycosylationandreversespdl1mediatedimmunesuppression
AT chongzhao deltatocotrienoldisruptspdl1glycosylationandreversespdl1mediatedimmunesuppression
AT lihongfan deltatocotrienoldisruptspdl1glycosylationandreversespdl1mediatedimmunesuppression
AT shutaoyin deltatocotrienoldisruptspdl1glycosylationandreversespdl1mediatedimmunesuppression
AT hongbohu deltatocotrienoldisruptspdl1glycosylationandreversespdl1mediatedimmunesuppression